Dr Zorana Ltd - Period Ending 2022-07-31

Dr Zorana Ltd - Period Ending 2022-07-31


Dr Zorana Ltd 13527454 false 2021-07-23 2022-07-31 2022-07-31 The principal activity of the company is general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true true 13527454 2021-07-23 2022-07-31 13527454 2022-07-31 13527454 core:RetainedEarningsAccumulatedLosses 2022-07-31 13527454 core:ShareCapital 2022-07-31 13527454 core:CurrentFinancialInstruments core:WithinOneYear 2022-07-31 13527454 bus:SmallEntities 2021-07-23 2022-07-31 13527454 bus:AuditExemptWithAccountantsReport 2021-07-23 2022-07-31 13527454 bus:AbridgedAccounts 2021-07-23 2022-07-31 13527454 bus:SmallCompaniesRegimeForAccounts 2021-07-23 2022-07-31 13527454 bus:RegisteredOffice 2021-07-23 2022-07-31 13527454 bus:Director1 2021-07-23 2022-07-31 13527454 bus:Director2 2021-07-23 2022-07-31 13527454 bus:PrivateLimitedCompanyLtd 2021-07-23 2022-07-31 13527454 1 2021-07-23 2022-07-31 13527454 countries:England 2021-07-23 2022-07-31 iso4217:GBP xbrli:pure

Registration number: 13527454

Dr Zorana Ltd

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Period from 23 July 2021 to 31 July 2022

 

Dr Zorana Ltd

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Dr Zorana Ltd

(Registration number: 13527454)
Abridged Balance Sheet as at 31 July 2022

Note

2022
£

Current assets

 

Debtors

4

2,751

Cash at bank and in hand

 

19,033

 

21,784

Creditors: Amounts falling due within one year

(4,969)

Net assets

 

16,815

Capital and reserves

 

Called up share capital

2

Profit and loss account

16,813

Total equity

 

16,815

For the financial period ending 31 July 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 12 July 2023 and signed on its behalf by:
 

Dr S Zorana

Director

Mr A Uvaise

Director

 

Dr Zorana Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 23 July 2021 to 31 July 2022

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
74 Racecourse Road
Newbury
Berkshire
RG14 7GH

These financial statements were authorised for issue by the Board on 12 July 2023.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Disclosure of long or short period

The accounting period reported on exceeds 12 months due to it being the first post incorporation period, subsequent periods will be 12 months in length.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Dr Zorana Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 23 July 2021 to 31 July 2022

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 0.

4

Debtors

Debtors includes £Nil due after more than one year.